Inside-Filings
Projekt anfragen

MYRIAD GENETICS INC (MYGN)

Sentiment-Signal

29,9
Bearisch
Composite Score (0–100)
Insider (25%)
72.8
2 Insider, 666K $ Volumen
Institutionell (22,5%)
7.1
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
03.10.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECo Section 13(a) of the Exchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo
21.12.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECo Section 13(a) of the Exchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo
01.11.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECo Section 13(a) of the Exchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo
05.10.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECction 13(a) of the Exchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm

Stammdaten

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Unternehmen & Branche

NameMYRIAD GENETICS INC
TickerMYGN
CIK0000899923
BoerseUS
SektorHealthcare
IndustrieMedical - Diagnostics & Research
SIC2835 · In Vitro & In Vivo Diagnostic Substances

Wertpapier & Kennzahlen

CUSIP62855J104
ISINUS62855J1043
TypCommon Stock
Marktkapitalisierung477,4 Mio. USD
Beta1,64
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K824,500,000-365,900,000-3.95706,600,000368,000,000
2025-09-3010-Q205,700,000-27,400,000-0.29728,100,000372,800,000
2025-06-3010-Q213,100,000-330,500,000-3.57677,300,000388,100,000
2025-03-3110-Q195,900,000-100,0000.001,006,100,000704,900,000
2024-12-3110-K837,600,000-127,300,000-1.411,027,600,000701,100,000
2024-09-3010-Q213,300,000-22,100,000-0.241,081,300,000731,700,000
2024-06-3010-Q211,500,000-36,700,000-0.411,085,100,000740,500,000
2024-03-3110-Q202,200,000-26,000,000-0.291,110,500,000760,000,000
2023-12-3110-K753,200,000-263,300,000-3.181,146,500,000783,200,000
2023-09-3010-Q191,900,000-61,300,000-0.751,149,100,000683,400,000
2023-06-3010-Q183,500,000-116,100,000-1.421,187,200,000735,200,000
2023-03-3110-Q181,200,000-54,700,000-0.671,169,300,000835,200,000
2022-12-3110-K678,400,000-112,000,000-1.391,198,700,000885,800,000
2022-09-3010-Q156,400,000-35,100,000-0.431,212,000,000916,600,000
2022-06-3010-Q179,300,000-14,100,000-0.181,210,200,000947,400,000
2022-03-3110-Q164,900,000-20,500,000-0.261,255,400,000950,100,000
2021-12-3110-K690,600,000-27,200,000-0.351,320,700,000967,800,000
2021-09-3010-Q167,300,00024,600,0000.301,335,900,000968,600,000
2021-06-3010-Q189,400,000-4,700,000-0.061,360,300,000902,500,000
2021-03-3110-Q173,100,000-39,500,000-0.521,336,900,000875,200,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
BlackRock, Inc.15,303,850015,303,85094,118,678Neu+100,0%
VANGUARD GROUP INC8,225,37108,225,37150,586,032Neu+100,0%
MILLENNIUM MANAGEMENT LLC6,700,15806,700,15841,205,972Neu+100,0%
STATE STREET CORP5,966,56705,966,56736,694,387Neu+100,0%
D. E. Shaw & Co., Inc.4,505,19304,505,19327,706,937Neu+100,0%
MORGAN STANLEY3,607,78903,607,78922,187,902Neu+100,0%
JACOBS LEVY EQUITY MANAGEMENT, INC2,270,37802,270,37813,962,825Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC2,231,29202,231,29213,725,274Neu+100,0%
GOLDMAN SACHS GROUP INC2,160,28202,160,28213,285,734Neu+100,0%
AQR CAPITAL MANAGEMENT LLC1,870,38501,870,38511,502,869Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,753,71101,753,71110,785,322Neu+100,0%
DIMENSIONAL FUND ADVISORS LP1,287,44701,287,4477,917,835Neu+100,0%
Vestal Point Capital, LP1,223,00001,223,0007,521,450Neu+100,0%
Fisher Asset Management, LLC1,207,01901,207,0197,423,165Neu+100,0%
Assenagon Asset Management S.A.1,167,73401,167,7347,181,564Neu+100,0%
Connor, Clark & Lunn Investment Management Ltd.1,156,69201,156,6927,113,656Neu+100,0%
NORTHERN TRUST CORP1,126,65801,126,6586,928,946Neu+100,0%
TWO SIGMA INVESTMENTS, LP915,1710915,1715,628,302Neu+100,0%
Aberdeen Group plc885,8010885,8015,447,676Neu+100,0%
Qube Research & Technologies Ltd873,1260873,1265,369,725Neu+100,0%
BANK OF AMERICA CORP /DE/867,0710867,0715,332,486Neu+100,0%
Walleye Capital LLC677,1760677,1764,164,632Neu+100,0%
UBS Group AG639,6910639,6913,934,100Neu+100,0%
ROYCE & ASSOCIATES LP605,0000605,0003,720,750Neu+100,0%
Trexquant Investment LP542,4950542,4953,336,344Neu+100,0%
AMERIPRISE FINANCIAL INC525,3220525,3223,230,732Neu+100,0%
Invesco Ltd.507,1800507,1803,119,157Neu+100,0%
FMR LLC490,9450490,9453,019,312Neu+100,0%
PRINCIPAL FINANCIAL GROUP INC444,1480444,1482,731,511Neu+100,0%
WELLS FARGO & COMPANY/MN437,0340437,0342,687,760Neu+100,0%
CANADA PENSION PLAN INVESTMENT BOARD436,9000436,9002,686,935Neu+100,0%
Susquehanna Portfolio Strategies, LLC383,6570383,6572,359,491Neu+100,0%
JPMORGAN CHASE & CO380,0680380,0682,337,418Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC379,3740379,3742,333,150Neu+100,0%
NORDEA INVESTMENT MANAGEMENT AB369,1510369,1512,264,741Neu+100,0%
Y-Intercept (Hong Kong) Ltd356,8930356,8932,194,892Neu+100,0%
Squarepoint Ops LLC343,7430343,7432,114,019Neu+100,0%
PUBLIC SECTOR PENSION INVESTMENT BOARD322,4150322,4151,982,852Neu+100,0%
ExodusPoint Capital Management, LP313,3700313,3701,927,226Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS304,9740304,9741,875,590Neu+100,0%
BARCLAYS PLC301,7880301,7881,855,997Neu+100,0%
CITADEL ADVISORS LLC290,1710290,1711,784,552Neu+100,0%
STATE OF WISCONSIN INVESTMENT BOARD287,6170287,6171,768,845Neu+100,0%
RHUMBLINE ADVISERS275,8590275,8591,696,511Neu+100,0%
INTECH INVESTMENT MANAGEMENT LLC228,7790228,7791,406,991Neu+100,0%
IEQ CAPITAL, LLC228,0050228,0051,402,231Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC224,1330224,1331,378,419Neu+100,0%
Legal & General Group Plc220,4720220,4721,355,905Neu+100,0%
Swiss National Bank183,4000183,4001,127,910Neu+100,0%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO137,4470137,447845,299Neu+100,0%

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-03-09Raha Samraat S.Director, Officer, President and CEOOpen Market Purchase40,0005.00199,844.00+115,1%
2026-02-27Phanstiel S. LouiseDirectorOpen Market Purchase48,0004.66223,728.00+128,8%
2026-02-26Phanstiel S. LouiseDirectorOpen Market Purchase50,4074.80242,104.82+139,4%
2026-02-25Phanstiel S. LouiseDirectorOpen Market Purchase6,1004.7428,889.60+16,6%

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-247194,663.351
2026-03-232.8104,5812.870
2026-03-2094,7543
2026-03-191.5094,647.002
2026-03-132974,851.440
2026-03-041175,29619
2026-02-242.0004,388.760

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
BlackRock, Inc.15,303,85094,118,67819.34
VANGUARD GROUP INC8,225,37150,586,03210.40
MILLENNIUM MANAGEMENT LLC6,700,15841,205,9728.47
STATE STREET CORP5,966,56736,694,3877.54
D. E. Shaw & Co., Inc.4,505,19327,706,9375.69
MORGAN STANLEY3,607,78922,187,9024.56
JACOBS LEVY EQUITY MANAGEMENT, INC2,270,37813,962,8252.87
GEODE CAPITAL MANAGEMENT, LLC2,231,29213,725,2742.82
GOLDMAN SACHS GROUP INC2,160,28213,285,7342.73
AQR CAPITAL MANAGEMENT LLC1,870,38511,502,8692.36
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,753,71110,785,3222.22
DIMENSIONAL FUND ADVISORS LP1,287,4477,917,8351.63
Vestal Point Capital, LP1,223,0007,521,4501.55
Fisher Asset Management, LLC1,207,0197,423,1651.53
Assenagon Asset Management S.A.1,167,7347,181,5641.48
Connor, Clark & Lunn Investment Management Ltd.1,156,6927,113,6561.46
NORTHERN TRUST CORP1,126,6586,928,9461.42
TWO SIGMA INVESTMENTS, LP915,1715,628,3021.16
Aberdeen Group plc885,8015,447,6761.12
Qube Research & Technologies Ltd873,1265,369,7251.10

Hinweis

Erweitert ×